Statistics for Zomedica Pharmaceuticals (id:169 ZOM)
Valuation metrics
Market cap
117,59M
Enterprise value
42,04M
Trailing P/E (ttm)
-3,74
Forward P/E
-14,59
PEG ratio
5,00
Price/Sales (ttm)
4,51
Price/Book (mrq)
3,00
Enterprise Value/Revenue
1,61
Enterprise Value/EBITDA
-1,43
Overview
Shares outstanding
979,95M
Float
961,51M
Shares short
51,14M
% Held by insiders
5,00%
% Held by institutions
5,00%
Average volume (10 days)
4,68M
Average volume (90 days)
Price summary
52-Week low
3,00
52-Week high
3,00
52-Week change
-29,77%
Beta
1,06
50-Day moving average
3,00
200-Day moving average
3,00
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0,00%
Trailing annual dividend yield
0,00
5-Year annual dividend yield
Payout ratio
0,00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-214,70%
Operating margin
-147,50%
Operational effectiveness
Return on assets
-9,29%
Return on equity
-23,92%
Income statement
Revenue (ttm)
5,00
Revenue per share (ttm)
5,00
Quarterly revenue growth (yoy)
3,00
Gross profit (ttm)
17,32M
EBITDA
-29.393.000,00
Net income to common (ttm)
-55.986.000,00
Diluted EPS (ttm)
5,00
Quarterly earnings growth (yoy)
10,24%
Balance sheet
Total cash (mrq)
79,51M
Total cash per share (mrq)
5,00
Total debt (mrq)
2,29M
Total Debt/Equity (mrq)
1,10
Current ratio (mrq)
1,14K%
Book value per share (mrq)
3,00
Cash flow
Cash flow statement
-22.351.000,00
Levered free cash flow (LFCF)
-23.166.750,00